ClinicalTrials.Veeva

Menu
H

Hamzavi Dermatology | Canton

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Relugolix
TNX-102
Estradiol
JNJ-77242113
Norethindrone Acetate

Parent organization

This site is a part of Hamzavi Dermatology

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

The purpose of the study is to evaluate how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo an...

Active, not recruiting
Plaque Psoriasis
Drug: Deucravacitinib Matching Placebo
Drug: JNJ-77242113 Matching Placebo

To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.

Active, not recruiting
Vitiligo
Device: RECELL® Autologous Cell Harvesting Device

Trial sponsors

M
Tonix Pharmaceuticals logo
A
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems